我国现阶段猴痘疫情防控策略优势、劣势、机会及威胁分析

陈琦; 吴杨; 陈楚鼎; 黄丹钦; 童叶青; 官旭华

doi:10.11847/zgggws1140743

我国现阶段猴痘疫情防控策略优势、劣势、机会及威胁分析

doi: 10.11847/zgggws1140743

湖北省预防控制中心，湖北武汉 430079

详细信息

作者简介:
陈琦（1985 – ），女，湖北武汉人，副主任医师，硕士，研究方向：传染病防控和卫生应急工作

通讯作者:
童叶青，E-mail：63382251@qq.com

官旭华，E-mail：guanxh9999@163.com

中图分类号: R 184.6
计量
- 文章访问数: 53
- HTML全文浏览量: 13
- PDF下载量: 9
- 被引次数: 0
出版历程
- 接收日期: 2022-11-02
- 网络出版日期: 2023-03-31
- 刊出日期: 2023-04-10

Strategy for prevention and control of mpox epidemic in China: a strengths, weaknesses, opportunities and threats (SWOT) analysis

Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei Province 430079, China

摘要

摘要: 2022年7月23日，世界卫生组织宣布猴痘疫情为“国际关注的突发公共卫生事件”，说明猴痘疫情已经到了非常严重的地步。猴痘是由猴痘病毒感染引起的一种罕见的人兽共患传染病，虽然目前报告的猴痘病例大多数为男男性行为者，但全人群易感，输入风险大。优势、劣势、机会和威胁（strengths weaknesses opportunities and threats, SWOT）分析方法是指通过对研究对象密切相关的主要优势、劣势、机会、威胁及其他影响因素的综合分析，得出相应的结论。本文借鉴应对2003年严重急性呼吸综合征（severe acute respiratory syndromes, SARS）疫情和3年来新型冠状病毒感染疫情的防控经验，采用SWOT分析方法系统分析了我国现阶段猴痘疫情防控策略的优势、劣势、机会及威胁，为猴痘疫情防控的科学决策提供参考。
- 猴痘 /
- SWOT分析 /
- 优势 /
- 劣势 /
- 机会
Abstract: On July 23, 2022, the World Health Organization (WHO) declared the mpox epidemic as a Public Health Emergency of International Concern (PHEIC), indicating the seriousness of the mpox epidemic. Mpox is a rare zoonotic infectious disease caused by mpox virus infection, mostly occurred among the men who have sex with men (MSM), but general populations are susceptible to the infection and the risk of imported infection is high. In this paper, we discussed the strategy for prevention and control of mpox epidemic in China using strengths, weaknesses, opportunities and threats (SWOT) analysis based on the experience in the containment of severe acute respiratory syndromes (SARS) in 2003 and coronavirus disease 2019 (COVID - 19) in recent three years, for providing a reference to relevant decision - making.
- mpox /
- SWOT analysis /
- strength /
- weakness /
- opportunity

HTML全文

参考文献(35)

[1]	Reed KD, Melski JW, Graham MB, et al. The detection of monkeypox in humans in the western Hemisphere[J]. The New England Journal of Medicine, 2004, 350(4): 342 – 350. doi: 10.1056/NEJMoa032299
[2]	World Health Organization. Multi-country outbreak of mpox, External situation report #11 – 1 December 2022[EB/OL]. (2022 – 11 – 01)[2022 – 11 – 01]. https://www.who.int/publications/m/item/multi-country-outbreak-of-mpox--external-situation-report--11---1-december-2022.
[3]	Thakur V, Thakur P, Srivastava S, et al. Monkeypox virus (MPX) in humans a concern: trespassing the global boundaries – corre-spondence[J]. International Journal of Surgery, 2022, 104: 106703. doi: 10.1016/j.ijsu.2022.106703
[4]	Rodriguez-Morales AJ, Lopardo G. Monkeypox: another sexually transmitted infection?[J]. Pathogens, 2022, 11(7): 713. doi: 10.3390/pathogens11070713
[5]	Durski KN, McCollum AM, Nakazwa Y, et al. Emergence of monkeypox – West and Central Africa, 1970 – 2017[J]. Morbidity and Mortality Weekly Report, 2018, 67(10): 306 – 310. doi: 10.15585/mmwr.mm6710a5
[6]	Singhal T, Kabra SK, Lodha R. Monkeypox: a review[J]. Indian Journal of Pediatrics, 2022, 89(10): 955 – 960. doi: 10.1007/s12098-022-04348-0
[7]	Zhao H, Wang WL, Zhao L, et al. The first imported case of monkeypox in the mainland of China – Chongqing municipality, China, September 16, 2022[J]. China CDC Weekly, 2022, 4(38): 853 – 854.
[8]	World Health Organization. Second meeting of the International Health Regulations (2005) (IHR) Emergency Committee regarding the multi-country outbreak of monkeypox[EB/OL]. (2022 – 07 – 23)[2022 – 11 – 01].https://www.who.int/news/item/23 – 07 – 2022-second-meeting-of-the-international-health-regulations-(2005)-(ihr)-emergency-committee-regarding-the-multi-country-outbreak-of-monkeypox.
[9]	Hernandez N, Gina Núñez-Mchiri G, Heyman J, et al. The use of a SWOT analysis to evaluate a COVID-19 mitigation project in the Paso del Norte Region[J]. Health Promotion Practice, 2022, 3: 15248399221118892.
[10]	蒋作君. 关于进一步明确社区卫生服务机构职能把健康中国战略落到实处的建议[J]. 中国发展, 2021, 21(1): 3 – 4.
[11]	卫生健康委. 国家卫生健康委关于印发“十四五”卫生健康人才发展规划的通知(国卫人发〔2022〕27号)[EB/OL]. (2022 – 08 – 03)[2022 – 11 – 01]. http://www.gov.cn/zhengce/zhengceku/2022-08/18/content_5705867.htm.
[12]	国务院. 突发公共卫生事件应急条例[EB/OL]. (2020 – 12 – 26)[2022 – 11 – 01]. http://www.gov.cn/zhengce/2020-12/26/content_5574586.htm.
[13]	国务院. 国家突发公共事件总体应急预案[EB/OL]. (2021 – 01 – 05)[2022 – 11 – 01].https://www.shanghai.gov.cn/nw32020/20210105/0001-32020_858090.html.
[14]	国务院. 国家突发公共卫生事件应急预案[EB/OL]. (2006 – 02 – 26)[2022 – 11 – 01]. http://www.gov.cn/yjgl/2006-02/26/content_211654.htm.
[15]	国务院. 国家突发公共事件医疗卫生救援应急预案[EB/OL]. (2006 – 02 – 26)[2022 – 11 – 01]. http://www.gov.cn/yjgl/2006-02/26/content_211628.htm.
[16]	Gong QZ, Wang CL, Chuai X, et al. Monkeypox virus: a re - emergent threat to humans[J]. Virologica Sinica, 2022, 37(4): 477 – 482. doi: 10.1016/j.virs.2022.07.006
[17]	Petersen E, Kantele A, Koopmans M, et al. Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and preven-tion[J]. Infectious Disease Clinics of North America, 2019, 33(4): 1027 – 1043. doi: 10.1016/j.idc.2019.03.001
[18]	CDC. Mpox[EB/OL]. (2022 – 11 – 07)[2022 – 11 – 01].https://www.cdc.gov/poxvirus/monkeypox/response/2022/index.html.
[19]	Okyay RA, Bayrak E, Kaya E, et al. Another epidemic in the sha-dow of COVID-19 pandemic: a review of monkeypox[J]. Eurasian Journal of Medicine and Oncology, 2022, 6(2): 95 – 99.
[20]	国家卫生健康委办公厅, 国家中医药管理局办公室. 猴痘诊疗指南(2022年版)[J]. 中国感染控制杂志, 2022, 21(6): 600 – 601.
[21]	Sejvar JJ, Chowdary Y, Schomogyi M, et al. Human monkeypox infection: a family cluster in the midwestern United States[J]. The Journal of Infectious Diseases, 2004, 190(10): 1833 – 1840. doi: 10.1086/425039
[22]	Hutson CL, Olson VA, Carroll DS, et al. A prairie dog animal model of systemic orthopoxvirus disease using West African and Congo Basin strains of monkeypox virus[J]. Journal of General Virology, 2009, 90(2): 323 – 333. doi: 10.1099/vir.0.005108-0
[23]	Chen NH, Li GY, Liszewski MK, et al. Virulence differences between monkeypox virus isolates from West Africa and the Congo Basin[J]. Virology, 2005, 340(1): 46 – 63. doi: 10.1016/j.virol.2005.05.030
[24]	Di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis[J]. The Lancet Infectious Diseases, 2004, 4(1): 15 – 25. doi: 10.1016/S1473-3099(03)00856-9
[25]	Kaler J, Hussain A, Flores G, et al. Monkeypox: a comprehensive review of transmission, pathogenesis, and manifestation[J]. Cureus, 2022, 14(7): e26531.
[26]	国家统计局. 中华人民共和国2021年国民经济和社会发展统计公报[EB/OL]. (2022 – 02 – 28)[2022 – 11 – 01]. http://www.gov.cn/xinwen/2022-02/28/content_5676015.htm.
[27]	Mahase E. Monkeypox: what do we know about the outbreaks in Europe and North America[J] BMJ, 2022, 377: o1274.
[28]	Grant R, Nguyen LBL, Breban R. Modelling human - to-human transmission of monkeypox[J]. Bulletin of the World Health Organization, 2020, 98(9): 638 – 640. doi: 10.2471/BLT.19.242347
[29]	World Health Organization. WHO expert meeting on evaluation of traditional Chinese medicine in the treatment of COVID-19[EB/OL]. (2022 – 03 – 31)[2022 – 11 – 01].https://www.who.int/publications/m/item/who-expert-meeting-on-evaluation-of-traditional-chinese-medicine-in-the-treatment-of-covid-19.
[30]	国家卫生健康委员会办公厅, 国家中医药管理局办公室. 关于印发新型冠状病毒肺炎诊疗方案(试行第九版)的通知(国卫办医函〔2022〕71号)[EB/OL]. (2022 – 03 – 15)[2022 – 11 – 01]. http://www.nhc.gov.cn/yzygj/s7653p/202203/b74ade1ba4494583805a3d2e40093d88.shtml.
[31]	Reynolds MG, Doty JB, McCollum AM, et al. Monkeypox re - emergence in Africa: a call to expand the concept and practice of One Health[J]. Expert Review of Anti-infective Therapy, 2019, 17(2): 129 – 139. doi: 10.1080/14787210.2019.1567330
[32]	Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy[J]. PLoS Neglected Tropical Diseases, 2019, 13(10): e0007791. doi: 10.1371/journal.pntd.0007791
[33]	Patrono LV, Pléh K, Samuni L, et al. Monkeypox virus emergence in wild chimpanzees reveals distinct clinical outcomes and viral diversity[J]. Nature Microbiology, 2020, 5(7): 955 – 965.
[34]	Fine PEM, Jezek Z, Grab B, et al. The transmission potential of monkeypox virus in human populations[J]. International Journal of Epidemiology, 1988, 17(3): 643 – 650. doi: 10.1093/ije/17.3.643
[35]	Simpson K, Heymann D, Brown CS, et al. Human monkeypox – after 40 years, an unintended consequence of smallpox eradication[J]. Vaccine, 2020, 38(33): 5077 – 5081. doi: 10.1016/j.vaccine.2020.04.062